Valuation: Diaceutics PLC

Market Cap 173M 231M 207M 191M 323M 21.97B 329M 2.27B 913M 11.56B 869M 850M 36.45B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 165M 221M 198M 182M 308M 20.99B 314M 2.17B 872M 11.04B 830M 812M 34.82B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 2.88x
Free-Float
72%
Yield 2026 *
-
Yield 2027 * -
1 week+4.36%
Current month+6.27%
1 month+6.27%
3 months+49.08%
6 months+22.96%
Current year+58.98%
1 week 197
Extreme 197
205
1 month 190
Extreme 190
210
Current year 125
Extreme 125
210
1 year 125
Extreme 125
210
3 years 82.5
Extreme 82.5
210
5 years 74
Extreme 74
210
10 years 74
Extreme 74
210
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
5/5/26 Buy

Chief Financial Officer

90 0.0001%
5/5/26 Free

Chief Financial Officer

90 0.0001%
5/5/26 Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.36%+26.01%+143.71% 231M
+0.74%+1.39%+19.87%+77.45% 769B
+0.80%-1.91%+19.48%+74.87% 87.29B
-2.39%+6.48%+36.22%+184.72% 72.45B
+0.11%-0.02%-16.08%+11.67% 47.36B
-10.38%-2.90%+24.13%+713.83% 42.25B
-0.95%-0.31%+3.11%+94.34% 46.08B
-0.82%+6.51%+22.71%+46.18% 34.27B
+0.75%-1.84%+57.23%+80.15% 26.33B
+3.18%+0.32%-23.27%-55.71% 26.6B
Average +0.41%+1.21%+16.94%+137.12% 115.19B
Weighted average by Cap. +0.54%+1.23%+18.82%+101.38%

Financials

2026 *2027 *
Net sales 46.72M 62.59M 56.05M 51.56M 87.33M 5.94B 88.96M 615M 247M 3.13B 235M 230M 9.86B 56.34M 75.48M 67.6M 62.18M 105M 7.17B 107M 742M 298M 3.77B 283M 277M 11.89B
Net income -1.1M -1.47M -1.32M -1.21M -2.06M -140M -2.09M -14.48M -5.81M -73.6M -5.53M -5.41M -232M 2.85M 3.82M 3.42M 3.15M 5.33M 363M 5.43M 37.51M 15.06M 191M 14.33M 14.02M 601M
Net Debt -7.73M -10.35M -9.27M -8.53M -14.45M -983M -14.72M -102M -40.84M -517M -38.86M -38.03M -1.63B -10.4M -13.93M -12.47M -11.47M -19.43M -1.32B -19.8M -137M -54.92M -696M -52.27M -51.15M -2.19B
Projected Income Statement - Annual - Diaceutics PLC
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
30/10/26 GBX 203.50 0.00% 40,353
29/10/26 GBX 203.50 0.00% 17,556
28/10/26 GBX 203.50 +1.50% 26,477
27/10/26 GBX 200.50 +0.75% 337,091
26/10/26 GBX 199.00 +2.05% 37,247
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Diaceutics PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.035GBP
Average target price
2.130GBP
Spread / Average Target
+4.67%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Diaceutics PLC
  1. Stock Market
  2. Stocks
  3. DXRX Stock